Imagine a world where surgeries are precise, efficient, and almost error-free. Picture a scenario where a life-saving operation is performed not by a human surgeon but by an advanced robotic system guided by artificial intelligence. This isn't a distant future; this is the reality unfolding before
In 2024, Bangladesh faced an alarming dengue outbreak that overwhelmed healthcare systems, impacted lives, and prompted urgent action. This mosquito-borne viral infection, causing widespread concern annually, reached unprecedented levels, demanding immediate attention and intervention. The Rising
Schrödinger, Inc., a company renowned for its computational software in drug discovery, has navigated the biotech landscape for 35 years while traditionally refraining from associating its platform with artificial intelligence (AI). This distinct approach has set Schrödinger apart from pure
Understanding distinguishing factors between the common cold and flu is crucial for accurate diagnosis, effective treatment, and proper preventive measures. Despite exhibiting similar symptoms, these respiratory illnesses are caused by different viruses and vary significantly in severity. An
Bispecific antibodies (BsAbs) are reshaping targeted therapies with their unique ability to engage two distinct targets simultaneously. This breakthrough innovation significantly diverges from traditional monospecific monoclonal antibodies (mAbs), opening up new avenues for treating various
The article investigates the harmful impact of the Trump Administration's recent policies on global scientific collaboration and research funding, with a particular focus on Australian biomedical research. This analysis highlights the challenges faced by Australian universities and researchers due
